Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils

被引:87
作者
Mollinedo, F
Nakajima, M
Llorens, A
Barbosa, E
Callejo, S
Gajate, C
Fabra, A
机构
[1] UNIV VALLADOLID, CSIC, FAC MED, DEPT HUMAN ANAT, E-47005 VALLADOLID, SPAIN
[2] CIBA GEIGY JAPAN LTD, BIOORGAN RES DEPT, INT RES LABS, TAKARAZUKA, HYOGO, JAPAN
[3] HOSP DURANI REYNALS, INST RECERCA ONCOL, DEPT CANC & METASTASIS, E-08907 BARCELONA, SPAIN
关键词
D O I
10.1042/bj3270917
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of cell-surface adhesion proteins and the release of extracellular-matrix degradative enzymes constitute crucial processes for the attachment of neutrophils to the endothelium and for the subsequent extravasation of these cells through the endothelial layer. We have analysed in resting human neutrophils the subcellular localization of heparanase, a heparan-sulphate-degrading endoglycosidase that can degrade basement-membrane components, thereby facilitating neutrophil passage into the tissue during an inflammatory reaction. By subcellular fractionation of postnuclear supernatants from resting human neutrophils on continuous sucrose gradients, we have found that heparanase activity was mainly located in gelatinase-containing tertiary granules, Using a specific antibody, the 96-kDa heparanase protein was further located in the gelatinase-rich subcellular fractions. Following immunoblotting and immunoprecipitation analysis in the distinct subcellular fractions, we also found colocalization of heparanase and Mol (CD11b/CD18), a leucocyte integrin involved in the attachment of neutrophils to the endothelium, in the fractions enriched in gelatinase-containing tertiary granules. Treatment of human neutrophils with tumour necrosis factor or granulocyte/macrophage colony-stimulating factor induced an increase in the CD11b/CD18 cell-surface expression, as well as the release of both gelatinase (matrix metalloproteinase-9) and heparanase, but not of other granule markers, indicating a major co-localization of gelatinase, heparanase and CD11b/CD18 in the same organelle. Furthermore, confocal laser scanning microscopy using specific antibodies against gelatinase and heparanase revealed a major co-localization of both enzymes in intracellular cytoplasmic granules. The major localization of heparanase and CD11b/CD18 in the gelatinase-containing tertiary granule supports the notion that mobilization of this organelle can regulate extravasation of human neutrophils.
引用
收藏
页码:917 / 923
页数:7
相关论文
共 55 条
[1]   LEUKOCYTE ADHESION RECEPTORS ARE STORED IN PEROXIDASE-NEGATIVE GRANULES OF HUMAN-NEUTROPHILS [J].
BAINTON, DF ;
MILLER, LJ ;
KISHIMOTO, TK ;
SPRINGER, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (06) :1641-1653
[2]   DEVELOPMENT OF NEUTROPHILIC POLYMORPHONUCLEAR LEUKOCYTES IN HUMAN BONE MARROW - ORIGIN AND CONTENT OF AZUROPHIL AND SPECIFIC GRANULES [J].
BAINTON, DF ;
ULLYOT, JL ;
FARQUHAR, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 134 (04) :907-+
[3]  
BALSINDE J, 1991, J BIOL CHEM, V266, P15638
[4]   CHEMOATTRACTANT-REGULATED MOBILIZATION OF A NOVEL INTRACELLULAR COMPARTMENT IN HUMAN-NEUTROPHILS [J].
BORREGAARD, N ;
MILLER, LJ ;
SPRINGER, TA .
SCIENCE, 1987, 237 (4819) :1204-1206
[5]  
BORREGAARD N, 1993, EUR J HAEMATOL, V51, P187
[6]   BIOCHEMICAL AND MORPHOLOGICAL CHARACTERIZATION OF AZUROPHIL AND SPECIFIC GRANULES OF HUMAN NEUTROPHILIC POLYMORPHONUCLEAR LEUKOCYTES [J].
BRETZ, U ;
BAGGIOLINI, M .
JOURNAL OF CELL BIOLOGY, 1974, 63 (01) :251-269
[7]  
CARLOS TM, 1994, BLOOD, V84, P2068
[8]   PLATELET-DERIVED COLLAGENASE INHIBITOR - CHARACTERIZATION AND SUBCELLULAR-LOCALIZATION [J].
COOPER, TW ;
EISEN, AZ ;
STRICKLIN, GP ;
WELGUS, HG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (09) :2779-2783
[9]  
DEVARAJAN P, 1992, J BIOL CHEM, V267, P25228
[10]   RELEASE OF GELATINASE FROM A NOVEL SECRETORY COMPARTMENT OF HUMAN-NEUTROPHILS [J].
DEWALD, B ;
BRETZ, U ;
BAGGIOLINI, M .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (03) :518-525